XPOVIO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Karyopharm Therapeutics Inc.. The primary component is Selinexor.
| Product ID | 72237-103_0aa4ad93-ecc2-41b6-9668-ad45f3f32c61 |
| NDC | 72237-103 |
| Product Type | Human Prescription Drug |
| Proprietary Name | XPOVIO |
| Generic Name | Selinexor |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-05-19 |
| Marketing Category | NDA / |
| Application Number | NDA212306 |
| Labeler Name | Karyopharm Therapeutics Inc. |
| Substance Name | SELINEXOR |
| Active Ingredient Strength | 50 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-05-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 72237-101 | XPOVIO | selinexor |
| 72237-102 | XPOVIO | selinexor |
| 72237-103 | XPOVIO | selinexor |
| 72237-104 | XPOVIO | selinexor |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XPOVIO 87719728 not registered Live/Pending |
Karyopharm Therapeutics Inc. 2017-12-13 |
![]() XPOVIO 86418181 not registered Dead/Abandoned |
Karyopharm Therapeutics Inc. 2014-10-08 |